Quanterix (QTRX) Competitors $4.57 +0.03 (+0.66%) Closing price 08/15/2025 04:00 PM EasternExtended Trading$4.66 +0.09 (+1.97%) As of 08/15/2025 07:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock QTRX vs. SIBN, TRNS, EYPT, ALNT, AEHR, LAB, CTKB, SENS, QSI, and FEIMShould you be buying Quanterix stock or one of its competitors? The main competitors of Quanterix include SiBone (SIBN), Transcat (TRNS), Eyepoint Pharmaceuticals (EYPT), Allient (ALNT), Aehr Test Systems (AEHR), Standard BioTools (LAB), Cytek Biosciences (CTKB), Senseonics (SENS), Quantum-Si (QSI), and Frequency Electronics (FEIM). Quanterix vs. Its Competitors SiBone Transcat Eyepoint Pharmaceuticals Allient Aehr Test Systems Standard BioTools Cytek Biosciences Senseonics Quantum-Si Frequency Electronics Quanterix (NASDAQ:QTRX) and SiBone (NASDAQ:SIBN) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their risk, analyst recommendations, valuation, media sentiment, institutional ownership, earnings, profitability and dividends. Which has more volatility & risk, QTRX or SIBN? Quanterix has a beta of 1.07, suggesting that its share price is 7% more volatile than the S&P 500. Comparatively, SiBone has a beta of 0.91, suggesting that its share price is 9% less volatile than the S&P 500. Is QTRX or SIBN more profitable? SiBone has a net margin of -12.83% compared to Quanterix's net margin of -56.04%. SiBone's return on equity of -14.20% beat Quanterix's return on equity.Company Net Margins Return on Equity Return on Assets Quanterix-56.04% -18.41% -14.80% SiBone -12.83%-14.20%-10.38% Which has stronger valuation & earnings, QTRX or SIBN? SiBone has higher revenue and earnings than Quanterix. SiBone is trading at a lower price-to-earnings ratio than Quanterix, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioQuanterix$137.42M1.55-$38.53M-$1.82-2.51SiBone$167.18M3.99-$30.91M-$0.56-27.61 Do analysts rate QTRX or SIBN? Quanterix presently has a consensus price target of $11.75, suggesting a potential upside of 157.11%. SiBone has a consensus price target of $23.67, suggesting a potential upside of 53.08%. Given Quanterix's higher probable upside, research analysts plainly believe Quanterix is more favorable than SiBone.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Quanterix 0 Sell rating(s) 4 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.20SiBone 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do institutionals & insiders hold more shares of QTRX or SIBN? 86.5% of Quanterix shares are held by institutional investors. Comparatively, 98.1% of SiBone shares are held by institutional investors. 6.9% of Quanterix shares are held by insiders. Comparatively, 4.0% of SiBone shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Does the media prefer QTRX or SIBN? In the previous week, Quanterix had 3 more articles in the media than SiBone. MarketBeat recorded 7 mentions for Quanterix and 4 mentions for SiBone. Quanterix's average media sentiment score of 0.75 beat SiBone's score of 0.70 indicating that Quanterix is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Quanterix 0 Very Positive mention(s) 3 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SiBone 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummarySiBone beats Quanterix on 10 of the 16 factors compared between the two stocks. Get Quanterix News Delivered to You Automatically Sign up to receive the latest news and ratings for QTRX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding QTRX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart QTRX vs. The Competition Export to ExcelMetricQuanterixMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$212.35M$10.78B$5.75B$9.81BDividend YieldN/A1.97%3.91%4.13%P/E Ratio-2.5121.0931.1125.06Price / Sales1.5531.71433.9099.62Price / CashN/A24.3936.7858.67Price / Book0.733.399.086.18Net Income-$38.53M$211.77M$3.26B$265.11M7 Day Performance-3.79%13.40%7.38%4.22%1 Month Performance-17.06%9.87%4.21%0.77%1 Year Performance-63.15%-10.08%30.29%24.69% Quanterix Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)QTRXQuanterix2.3641 of 5 stars$4.57+0.7%$11.75+157.1%-63.1%$212.35M$137.42M-2.51460SIBNSiBone4.277 of 5 stars$17.90+2.9%$22.50+25.7%+11.5%$741.07M$167.18M-27.97350High Trading VolumeTRNSTranscat3.5393 of 5 stars$74.80+0.3%$112.20+50.0%-31.6%$694.69M$278.42M47.951,245News CoveragePositive NewsAnalyst RevisionEYPTEyepoint Pharmaceuticals1.9278 of 5 stars$10.06+3.6%$25.67+155.1%+39.8%$668.16M$43.27M-4.17120News CoverageALNTAllient2.7452 of 5 stars$39.67+4.3%$31.00-21.9%+108.1%$643.64M$516.06M67.242,525AEHRAehr Test Systems2.2489 of 5 stars$19.03+13.0%N/A+24.7%$503.77M$58.97M-146.3790Positive NewsLABStandard BioTools3.3467 of 5 stars$1.32+1.5%$2.50+89.4%-30.5%$493.77M$174.43M-3.77620News CoverageAnalyst DowngradeInsider TradeCTKBCytek Biosciences3.3136 of 5 stars$3.84+5.5%$5.60+45.8%-27.0%$461.04M$200.45M-42.66500SENSSenseonics2.2947 of 5 stars$0.51+3.9%$1.55+205.2%+14.5%$332.21M$23.68M-3.9190QSIQuantum-Si3.0673 of 5 stars$1.44-1.4%$3.48+141.3%+12.9%$267.91M$3.06M-2.12150FEIMFrequency Electronics1.5032 of 5 stars$27.73+4.8%N/A+139.3%$257.30M$69.81M11.23200News Coverage Related Companies and Tools Related Companies SIBN Alternatives TRNS Alternatives EYPT Alternatives ALNT Alternatives AEHR Alternatives LAB Alternatives CTKB Alternatives SENS Alternatives QSI Alternatives FEIM Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:QTRX) was last updated on 8/17/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Quanterix Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Quanterix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.